0000899243-20-013089.txt : 20200514 0000899243-20-013089.hdr.sgml : 20200514 20200514163106 ACCESSION NUMBER: 0000899243-20-013089 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200512 FILED AS OF DATE: 20200514 DATE AS OF CHANGE: 20200514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: aMoon 2 Fund Limited Partnership CENTRAL INDEX KEY: 0001744099 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39279 FILM NUMBER: 20878280 BUSINESS ADDRESS: STREET 1: 34 YERUSHALAYIM RD. CITY: RAANANA STATE: L3 ZIP: 4350110 BUSINESS PHONE: 972(73)3989560 MAIL ADDRESS: STREET 1: 34 YERUSHALAYIM RD. CITY: RAANANA STATE: L3 ZIP: 4350110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001797336 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823578375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: (857) 444-0553 MAIL ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-12 0 0001797336 Ayala Pharmaceuticals, Inc. AYLA 0001744099 aMoon 2 Fund Limited Partnership 34 YERUSHALAIM RD. BEIT GAMLA, 6TH FLOOR RA'ANANA L3 4350110 ISRAEL 0 0 1 0 Common Stock 2020-05-12 4 C 0 369231 0.00 A 1682549 D Common Stock 2020-05-12 4 C 0 508924 0.00 A 2191473 D Common Stock 2020-05-12 4 P 0 800000 15.00 A 2991473 D Series A Preferred Stock 2020-05-12 4 C 0 738462 D Common Stock 369231 0 D Series B Preferred Stock 2020-05-12 4 C 0 1017848 D Common Stock 508924 0 D Each share of preferred stock was automatically converted into 0.5 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date. /s/ Matthew Rudolph, Adv., Attorney-in-Fact for Yair Schindel 2020-05-14